Organon Reports Strong Q4 Earnings, Exceeding Expectations
JERSEY CITY, N.J. - Organon & Co. (OGN) reported net income of $109 million for the fourth quarter, translating to earnings per share of 42 cents. Adjusted for non-recurring items, earnings came in at 90 cents per share, surpassing Wall Street analysts' estimates of 86 cents per share.
The pharmaceutical company also exceeded revenue projections, posting $1.59 billion for the quarter, against analysts' estimates of $1.57 billion. For the full year, Organon reported net income of $864 million, equivalent to $3.33 per share, on revenue of $6.4 billion.
Looking ahead, Organon projects full-year revenue between $6.13 billion and $6.33 billion.
This article was generated by Automated Insights using data from Zacks Investment Research.